Maternal regulation of biliary disease in neonates via gut microbial metabolites

Jai Junbae Jee1,2, Li Yang1, Pranavkumar Shivakumar1,3

  • 1Divisions of Gastroenterology, Hepatology and Nutrition and The Liver Care Center at Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.

Nature Communications
|January 11, 2022
PubMed

Insights

Maternal butyrate intake protects newborns from biliary atresia by altering gut bacteria and metabolites. This finding offers potential therapeutic strategies for this severe neonatal liver disease.

Area of Science:

  • Microbiome research
  • Neonatal immunology
  • Gastroenterology

Background:

  • Maternal microbiome seeding influences neonatal health.
  • The impact on early-life disease susceptibility is unclear.
  • Biliary atresia is a severe neonatal cholangiopathy with unknown causes.

Purpose of the Study:

  • To investigate if maternal butyrate supplementation affects neonatal susceptibility to biliary atresia.
  • To identify microbial and metabolic changes associated with this protective effect.
  • To explore therapeutic potential of butyrate and glutamine in biliary atresia.

Main Methods:

  • Mice were fed butyrate during pregnancy.
  • Neonatal susceptibility to experimental biliary atresia was assessed.
  • Fecal microbiome and metabolome analyses were performed.
  • Butyrate and glutamine were administered to newborn mice.

Main Results:

  • Maternal butyrate reduced biliary atresia, inflammation, and injury in neonates.
  • Protection correlated with increased Bacteroidetes/Clostridia and altered glutamate/glutamine and hypoxanthine metabolites.
  • Human neonates with biliary atresia showed depleted beneficial bacteria and altered metabolite pathways.
  • Butyrate or glutamine administration attenuated disease in mice; glutamine enhanced bile duct cell survival.

Conclusions:

  • Maternal butyrate intake modulates the neonatal microbiome and metabolites, influencing experimental biliary atresia.
  • Specific microbial signatures and metabolic pathways are linked to disease protection.
  • Glutamine plays a role in protecting bile duct epithelial cells from cytotoxicity.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
83.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
261
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
295
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.0K